GlassScriptPhysician profile
Eric L Stewart
NPI 1023756525
$4,956.94
in general payments reported to CMS, 2019-2025
14 companies · $377 in 2025
The $377 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $4,580 · 2025: $377.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,288 · Food and Beverage: $669.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,288.18 |
| Food and Beverage | $668.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,288.18 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $244.74 | 2024-2025 | Breztri, Farxiga |
| Glaxosmithkline, LLC. | $141.49 | 2025 | Shingrix |
| Novartis Pharmaceuticals Corporation | $71.85 | 2024-2025 | |
| Lilly USA, LLC | $30.78 | 2024 | Jardiance, Mounjaro |
| Axsome Therapeutics, INC. | $27.96 | 2025 | Auvelity |
| Gilead Sciences, INC. | $25.71 | 2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $24.07 | 2024 | Xifaxan |
| Collegium Pharmaceutical, INC. | $20.48 | 2025 | Jornay Pm |
| Merck Sharp & Dohme LLC | $20.27 | 2024 | Bridion |
| Novo Nordisk INC | $17.11 | 2025 | Wegovy |
| Phathom Pharmaceuticals, INC. | $16.75 | 2025 | Voquezna |
| Biogen, INC. | $14.42 | 2025 | Skyclarys |
| Ardelyx, INC. | $13.13 | 2024 | Ibsrela |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Stewart listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.